[vc_row][vc_column width=”3/4″][vc_message] The Asia Pacific market laboratory filtration market is expected to have a CAGR of 8.16% for the forecast period of 2019-2027. The Asia Pacific market is geographically segregated into countries as China, India, Australia, Japan, South Korea and the rest of the Asia Pacific. The major growth driver for the market in the Asia…
The global viral vector vaccine manufacturing market is anticipated to progress with a CAGR of 18.19%, during the forecasting period of 2019-2027. Read more.
[vc_row][vc_column width=”3/4″][vc_message]The North American viral vector vaccines manufacturing market is expected to grow at a CAGR of 18.44% during the forecast period of 2019-2027. In the field of vaccines, viral vectors have shown promising results in human and veterinary pathogens that demand a broad spectrum of immune response from a host to gain control. The North…
[vc_row][vc_column width=”3/4″][vc_message]The viral vector vaccine manufacturing market in the European region is expected to grow at a CAGR of 18.23% during the forecast period of 2019-2027. In the present market scenario, Europe holds the largest market share in manufacturing and distribution of viral vector vaccines. A growing number of clinical trial discovery programs in the region…
[vc_row][vc_column width=”3/4″][vc_message] The Asia Pacific regional market for the manufacture of viral vector vaccines is expected to have CAGR of 18.01% during the forecast period of 2019-2027. Advanced viral vector vaccines for the treatment of chronic and infectious diseases are also expected to boost the growth of the market in the Asia-Pacific region. The strategies adopted…